| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Armed antibodies for cancer treatment: a promising tool in a changing era
|
Danielli, Riccardo
|
|
2014
|
64 |
1 |
p. 113-121
|
artikel
|
| 2 |
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013
|
Maio, Michele
|
|
2014
|
64 |
1 |
p. 131-135
|
artikel
|
| 3 |
Cancer stem cells: perspectives for therapeutic targeting
|
Maccalli, Cristina
|
|
2014
|
64 |
1 |
p. 91-97
|
artikel
|
| 4 |
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?
|
Calabrò, Luana
|
|
2014
|
64 |
1 |
p. 105-112
|
artikel
|
| 5 |
Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy
|
Simonovic, Snezana Zivancevic
|
|
2014
|
64 |
1 |
p. 75-82
|
artikel
|
| 6 |
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
|
Balasa, Balaji
|
|
2014
|
64 |
1 |
p. 61-73
|
artikel
|
| 7 |
Evaluation of complement proteins as screening markers for colorectal cancer
|
Storm, Line
|
|
2014
|
64 |
1 |
p. 41-50
|
artikel
|
| 8 |
Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer
|
Novinger, Leah J.
|
|
2014
|
64 |
1 |
p. 29-39
|
artikel
|
| 9 |
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies
|
Castelli, Chiara
|
|
2014
|
64 |
1 |
p. 83-89
|
artikel
|
| 10 |
Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment
|
Švajger, Urban
|
|
2014
|
64 |
1 |
p. 15-27
|
artikel
|
| 11 |
Overcoming the toxicity hurdles of genetically targeted T cells
|
Casucci, Monica
|
|
2014
|
64 |
1 |
p. 123-130
|
artikel
|
| 12 |
Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
|
Kimura, Hideki
|
|
2014
|
64 |
1 |
p. 51-59
|
artikel
|
| 13 |
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer
|
Trajanoski, Zlatko
|
|
2014
|
64 |
1 |
p. 99-104
|
artikel
|
| 14 |
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
|
Messmer, Michelle N.
|
|
2014
|
64 |
1 |
p. 1-13
|
artikel
|
Tijdschrift beschrijving